Obstacles to cardiovascular prevention in general practice
暂无分享,去创建一个
Michel Jeanjean | Vincent Lorant | Benoit Boland | Dominique Paulus | D. Paulus | V. Lorant | F. Nackers | Régis De Muylder | Fabienne Nackers | M. Jeanjean | B. Boland | Régis De Muylder
[1] P. F. Kauff. Group , 2000, Elegant Design.
[2] J. Shepherd. Economics of lipid lowering in primary prevention: lessons from the West of Scotland Coronary Prevention Study. , 2001, The American journal of cardiology.
[3] A. Folsom,et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. , 1998, The New England journal of medicine.
[4] Chris Todd,et al. Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs. , 2002, Family practice.
[5] G. Mancia,et al. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.
[6] M. Abrahamowicz,et al. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.
[7] D. Jacobs,et al. Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial , 1992 .
[8] G. Breithardt,et al. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. , 2000, European heart journal.
[9] David R. Wood,et al. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. , 2001, European heart journal.
[10] J. Knottnerus,et al. Barriers to working according to cholesterol guidelines. A randomized controlled trial on implementation of national guidelines in 20 general practices , 1998 .
[11] G. Backer,et al. LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals , 2000 .
[12] G. Assmann,et al. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. , 1998, European heart journal.
[13] S. Marriott,et al. Using Clinical Guidelines , 1998 .
[14] W. Rosenberg,et al. Evidence based medicine: an approach to clinical problem-solving , 1995, BMJ.
[15] Philippe Amouyel,et al. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. , 1997 .
[16] D. Wood,et al. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001, The Lancet.
[17] D. De Bacquer,et al. Trends in coronary heart disease in two Belgian areas: results from the MONICA Ghent-Charleroi Study. , 1999, Journal of epidemiology and community health.
[18] J. Knottnerus,et al. Comparison of appropriateness of cholesterol testing in general practice with the recommendations of national guidelines: an audit of patient records in 20 general practices. , 1996, Quality in health care : QHC.
[19] H. Blackburn,et al. Primary prevention of coronary heart disease. , 1987, Circulation.
[20] Jeremy M. Grimshaw,et al. Using clinical guidelines , 1999 .
[21] T. Lancet,et al. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996, The Lancet.